Tamer Elbaz, MD
Pain Medicine · New York, NYNPI 1366479198
Payments from drug & device makers
Across 19 payments — averaging $199.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elliquence, LLC$3K
- Medtronic$341
- Nevro Corp.$155
- Curonix LLC$80
- Globus Medical$42
- Spinal Simplicity, LLC$41
- plus $134 from 6 others
What the payments were for
- Consulting fees$3,00079%
- Food & beverage$79321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elliquence, LLC | 1 | $3,000 |
| Medtronic | 2 | $341 |
| Nevro Corp. | 2 | $155 |
| Curonix LLC | 3 | $80 |
| Globus Medical | 2 | $42 |
| Spinal Simplicity, LLC | 2 | $41 |
| Amgen | 2 | $31 |
| Indivior Inc. | 1 | $28 |
| Convatec Inc. | 1 | $22 |
| Saluda Medical Americas, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Spinefrontier, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,793 in reported general payments places this provider in the 65th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $6,294 |
| MovantikNaloxegol Oxalate | 13 | $5,019 |
| Lidocaine | 24 | $3,289 |
| Diclofenac Sodium | 55 | $2,087 |
| Diclofenac Sodium ErDiclofenac Sodium | 22 | $1,641 |
| Pregabalin | 35 | $1,430 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $742 |
| Gabapentin | 58 | $561 |
| Oxycodone Hcl | 30 | $451 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $324 |
| Cyclobenzaprine Hcl | 58 | $309 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $281 |
| Baclofen | 25 | $211 |
| Methadone Hcl | 20 | $191 |
| Tramadol Hcl | 23 | $123 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New York
- Amitabh GulatiNew York$627K
- David SpinnerNew York$391K
- Eric LeeNew York$156K
- Christopher GhariboNew York$94K
- Randa JaafarNew York$87K
- Boris LeybelNew York$58K
- Chirag ShahNew York$48K
- Annie Layno-MosesNew York$29K
- Raj MurthyNew York$24K
- David CassagnolNew York$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.